ADDITIONAL INDICATIONS FOR USE
Screening for peripheral neuropathy is not limited patients at risk for diabetes or diagnosed with diabetes. As product development has progressed, additional areas of incident have been identified via published papers and feedback from experts. These potential areas of incident include:
- Occupational exposure
- Antihypertensive and metabolic medications:
- Amiodarone
- Statins
- Perhexiline
- Hydralazine
- Chemotherapy
- Cisplatin
- Docetaxel
- Paclitaxel
- Suramin
- Vincristine
- Antibacterial and antiparasitic medications
- Chloroquine
- Isoniazid (INH)
- Metronidazole (Flagyl)
- Nitrofurantoin
- Thalidomide
- Cipro
- Drugs used to treat autoimmune disease
- Etanercept
- Infliximab
- Leflunomide
- Drugs used to treat skin conditions (Dapsone)
- Anticonvulsants (phenytoin)
- Anti-alcohol drugs (disulfiram)
- Drugs to fight HIV
- Didanosine (Videx)
- Stavudine (Zerit)
- Zalcitabine (Hivid)
- Exposure to:
|
